Viewing Study NCT07272434


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-01-18 @ 6:59 PM
Study NCT ID: NCT07272434
Status: RECRUITING
Last Update Posted: 2025-12-09
First Post: 2025-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Sponsor: MAXVAX Biotechnology Limited Liability Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module